Zadie, I believe we may have enough evidence to do a Phase 3, but either way our recommendation is meaningless, it's up to the company to do what they wish. If the regulators permit a multiple cancer trial that includes pancreatic, I'm fine with that. I hope they permit Poly-ICLC or whatever other therapeutic they believe will make the vaccine more effective as it seems like most of the time they don't want to do such things even though we know it will be far more effective with it.
I suspect if a few of the regulators had the cancers we're looking at they'd find a way of finishing the trial far quicker.
Gary
Market Data 
Markets 
